Acclinate Logo
Talk to Our Team

As new trials continue to improve treatment options for patients with all types of cancer, it’s “never too soon to be talking about clinical trials” with your oncologist, says Dr. Pashtoon Kasi, a clinical assistant professor of internal medicine, hematology, oncology and blood and marrow transplantation at the University of Iowa Health Care.

While discussing his research into a new AI-based clinical trial search tool, Kasi opened up about why he feels patients and caregivers should not only consider trials a last resort but should rather be asking their doctors about what trial options exist at every point in the treatment journey, from diagnosis and beyond.

"If you look up any of the NCCN guidelines, I love their statement that the best treatment for any patient right now is a clinical trial,” said Kasi. “I can’t emphasize that more. It’s a topic that’s very close to my heart.

I think, both from a patient standpoint, especially with not just common cancer, but even rare cancers, and then even within rare cancer, rare aberrations, knowing which of these trials are an option.

One important learning point that I tell patients (and) caregivers all the time is, often people think of clinical trials as something that you do when you fail the run of the mill treatment. Or it’s something that you do when you’re out of options. That’s not entirely true. I would say, not true at all, for some of the new trials that are coming in oncology.

So, it’s never too soon to be talking about trials, trials should be a discussion at the time of diagnosis. A trial should be a discussion at every point your oncologist or your physician is making a change (in treatment), the first question that should come from a patient or caregiver standpoint is, is there a trial that I can sign up for before we just move on to whatever is next available.

For some of the cancers, you know, a lot of the guidelines often, even if you look up any of the NCCN guidelines, I love their statement that the best treatment for any patient right now is a clinical trial. And I can’t emphasize that more. It’s a topic that’s very close to my heart.

And it’s truly of value because a lot of the new trials are not necessarily generic, they’re focusing on a particular target, there is strong preclinical evidence. So you’re not necessarily just signing up for something that’s going to take, you know, a blind aim and things. Obviously, if we knew it was going to work, it wouldn’t be a trial. But the feasibility of them being pills, something that they can take easily with limited toxicity, there’s a lot of value to consider trials right now. And, again, should not be something that you would be the last line or when you’re out of options.”

Source: https://www.curetoday.com/view/why-it-s-never-too-soon-to-consider-clinical-trials-as-a-treatment-option

Recent Posts

patient and doctor talking
5 Min Read

Key Takeaways and Learnings The recent FDA diversity in clinical trials guidance emphasizes how sponsors plan on reaching specific representation goal...

Read More
doctor and patient talking
4 Min Read

Key Takeaways and Learnings Though engaging communities of color for clinical trials can be challenging, improvement is entirely possible and evident ...

Read More
How Pharmacists Can Advance Equitable Care
3 Min Read

Key Takeaways and Learnings The clinical research sector continues to face challenges in running representative trials. Pharmacists’ unique roles with...

Read More
Clinical Research Recruitment Strategies: Setting the Stage for Success
3 Min Read

Key Takeaways and Learnings: Clinical research recruiters face increasing pressure to improve their strategies to make trials more inclusive. Building...

Read More
Diversity Action Planning: 5 Myths About the FDA’s Recent Guidance
4 Min Read

Key Takeaways and Learnings Recent clinical research recommendations reinforce the need for robust and sustained community engagement. The FDA’s recen...

Read More
Traditional Clinical Trial Recruitment Companies: 7 Things They Miss
5 Min Read

Key Takeaways and Learnings Clinical trials fall short when communities of color are underrepresented. Trust and awareness are longstanding obstacles ...

Read More
Challenges of the Traditional Clinical Recruitment Process
4 Min Read

Key Takeaways and Learnings Many historically marginalized communities continue to be excluded from clinical trials. Traditional clinical recruitment ...

Read More
What Is Health Equity and Why Should Clinical Researchers Care?
4 Min Read

The past few years have laid bare many disparities in U.S. healthcare.On average, Black Americans live fewer years than white Americans— commonly due ...

Read More
Why Is Health Equity Important: Impacts on Communities of Color
5 Min Read

There are few people as seemingly healthy as Olympic gold medalists. But when sprinter Tori Bowie died in her home due to complications from childbirt...

Read More